Voveran TPM Gel 30gm Information
Voveran TPM Gel 30gm is a prescription medicine that is available as a Gel. Muscle Pain, Toothache, Rheumatic Pain are some of its major therapeutic uses. Secondary and off-label uses of Voveran TPM Gel 30gm have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Voveran TPM Gel 30gm. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Voveran TPM Gel 30gm can also lead to other problems, which have been listed below. Usually, these side effects of Voveran TPM Gel 30gm go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Voveran TPM Gel 30gm has a Severe effect for pregnant women and Mild effect on lactating mothers. It is important to know if Voveran TPM Gel 30gm has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Voveran TPM Gel 30gm related warnings section.
Voveran TPM Gel 30gm can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Voveran TPM Gel 30gm in conditions like Stomach Infection, Skin Rash, Stroke. Other conditions have been mentioned below in the Voveran TPM Gel 30gm contraindications section.
Besides this, Voveran TPM Gel 30gm may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Voveran TPM Gel 30gm, it is important to know that it is safe while driving, and is habit-forming.
Voveran TPM Gel 30gm Benefits & Uses
Voveran TPM Gel 30gm is used to treat the following -
Main Benefits
- Muscle Pain (Read More - Home Remedies for Muscle Aches)
- Toothache (Read More - Home remedies for toothache)
- Rheumatic Pain
Other Benefits
- Headache
- Joint Pain (Read More - How to Relieve Joint Pain Naturally: Best Home Remedies)
- Osteoarthritis
- Rheumatoid Arthritis
- Ankylosing spondylitis
- Gout (Read More - Home remedies for gout pain)
- Migraine (Read More - Home remedies for migraines)
- Leg Pain (Read More - Home remedies for leg pain and weakness)
- Body Pain (Read More - Home Remedies for Body Pain)
- Sciatica (Read More - Home Remedies for Sciatica: Alleviate Pain Naturally)
- Foot Pain (Read More - How to Ease Foot Pain at Home with Natural Techniques)
Voveran TPM Gel 30gm Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Voveran TPM Gel 30gm Side Effects
Based on research, the following side effects have been observed when Voveran TPM Gel 30gm is used -
Severe
- Nephrotoxic
- Constipation (Read More - Home remedies for constipation)
- Diarrhoea
- Pancreatic inflammation
- Liver Damage
Moderate
- Fluid Retention
- पेट दर्द
- Arrhythimia
Mild
- Skin Rash (Read More - DIY Skin Rash Relief: Simple Home Remedies That Work)
- Nausea or vomiting
Voveran TPM Gel 30gm Related Warnings
-
Is the use of Voveran TPM Gel 30gm safe for pregnant women?
Pregnant women may get severe side effects after taking Voveran. If you are pregnant, do not take Voveran without a doctor's advice.
Severe -
Is the use of Voveran TPM Gel 30gm safe during breastfeeding?
Voveran may have very limited harmful effects for breastfeeding women.
Mild -
What is the effect of Voveran TPM Gel 30gm on the Kidneys?
There may be some severe side effects of Voveran on your kidney. Do not take it unless a doctor says so.
Severe -
What is the effect of Voveran TPM Gel 30gm on the Liver?
Voveran can cause side effects that could harm the liver. So medical advice before taking it is necessary.
Severe -
What is the effect of Voveran TPM Gel 30gm on the Heart?
Voveran may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Moderate
Severe Interaction of Voveran TPM Gel 30gm with Other Drugs
Voveran TPM Gel 30gm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Voveran TPM Gel 30gm Contraindications
If you are suffering from any of the following diseases, you should not take Voveran TPM Gel 30gm unless your doctor advises you to do so -
- Edema
- Stomach Infection
- Gastrointestinal Bleeding
- Kidney Disease
- Skin Rash
- Heart Attack
- Stroke
- Asthma
- Anemia
- Heart Failure
- Liver Disease
- Peptic Ulcer
Frequently asked Questions about Voveran TPM Gel 30gm
-
Is this Voveran TPM Gel 30gm habit forming or addictive?
Forming a habit of Voveran TPM Gel 30gm has not been reported.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Voveran TPM Gel 30gm since it will not make you feel sleepy.
Safe -
Is it safe?
Yes, but take Voveran TPM Gel 30gm only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Voveran TPM Gel 30gm is not used to treat mental disorders.
No
Voveran TPM Gel 30gm Interactions with Food and Alcohol
-
Interaction between Food and Voveran TPM Gel 30gm
There isn't any research available on the side effects of taking Voveran TPM Gel 30gm with food.
Unknown -
Interaction between Alcohol and Voveran TPM Gel 30gm
Taking Voveran TPM Gel 30gm with alcohol can have severely harmful effects on your health.
Severe
See all substitutes for Voveran
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
